ARCHIVES

FDA Committee IK IL-2/LAK For Modified Group C

This article is from The Cancer Letter archive.

Vol. 13 No. 18 | May 1, 1987

Download PDF Visit The Full Archive

Related Articles

Shared Decisionmaking Called For In PSA Screening For Ages 55-69

May 31, 2013

National Lung Cancer Partnership Announces Annual Grant Competition

August 9, 2013

Broder’s Conundrum: How To Let Congress Know NCI Needs More Money Without Asking For it

March 17, 1989

Clinical Trials Approved By NCI CTEP Last Month

February 25, 2011

NTP Bioassay Reports Will Include Other Tests In Assessing Potential Human Risk

January 23, 1981

NCI Starts “Exceptional Responders” Study

September 26, 2014